Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model
Karauzum et al., PLoS One, 2013
Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections
Adhikari et al., J Infect Dis, 2012
Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia
Adhikari et al. PLoS One, 2012.
Potent Neutralization of Staphylococcal Enterotoxin B In Vivo by Antibodies that Block Binding to the T-Cell Receptor
Chen G, Karauzum H, Long H, Carranza D, Holtsberg FW,
IBT Receives Phase I SBIR grant from NIAID for development of neutralizing monoclonal antibodies against Marburg Virus
IBT in collaboration with the laboratory of Dr. Yuxing Li,
CARB-X FUNDS INTEGRATED BIOTHERAPEUTICS TO EXPAND THE DEVELOPMENT OF ITS STAPHYLOCOCCUS AUREUS VACCINE TO FACILITATE USE IN THE DEVELOPING WORLD
Freeze-dried version of vaccine would boost availability to the world,
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
IBT in collaboration with Dr. Daniel Nelson’s lab at University
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
IBT in collaboration with Dr. Daniel Nelson’s lab at University
Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)
Kailasan S, Kort T, Mukherjee I, Liao GC, Kanipakala T,
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman
